Hints and tips:
...Actavis has completed more than 20 acquisitions including in Europe, the US and India in recent months, but lost out to Barr Pharmaceuticals of the US late last year in a bid for Pliva of Croatia....
...It marks the latest chapter in the consolidation of the generic drugs sector, which has witnessed Teva’s $7.4bn takeover of Ivax, and Barr Pharmaceuticals’ purchase of Croatia’s Pliva for $2.5bn....
...It is also trying to win round Pliva, the Croa-tian generics manufacturer, which early this week re-buffed its unsolicited €1.6bn approach, saying it under- valued the company....
International Edition